What it said it expected, against what it reported
1 target with a reported result
Above the range
0
above the last range given
Within the range
1
of 1 range targets
Below the range
0
below the last range given
The numbers CAH said it expected, in its earnings releases, next to what it then reported for the same period. 4 full-year targets were dropped quietly: the next release, before the year ended, gave other targets for that year but said nothing about these.
Target by target
Each target, with the sentence it came from
| Target | What the company said | Reported | Result |
|---|---|---|---|
| Free cash flow (company-defined) Fiscal 2027 |
Given $3.50B to $4.00B release 2026-08-11
|
– | No standard number |
The company's wordsFiscal year 2027 outlook … Non-GAAP adjusted free cash flow $3.5 billion to $4.0 billion release 2026-08-11 | |||
| Diluted EPS (company-defined) Fiscal 2027 |
Given $12.40 to $12.60 release 2026-08-11
Raised $12.80 to $13.00 release 2026-11-05
|
– | No standard number |
The company's wordsThe company released its fiscal year 2027 outlook for non-GAAP diluted EPS of +13% to +15% growth 3 ($12.40 to $12.60). … Non-GAAP earnings per share $12.40 to $12.60 release 2026-08-11 Cardinal Health is raising its fiscal year 2027 guidance for non-GAAP diluted EPS to $12.80 to $13.00, from the previous range of $12.40 to $12.60. release 2026-11-05 | |||
| Free cash flow (company-defined) Fiscal 2026 (ended 2026-06-30) |
Given $3.00B to $3.50B release 2025-10-30
|
– | No standard number |
The company's wordsCardinal Health raises fiscal year 2026 non-GAAP EPS guidance … to $9.65 to $9.85 and fiscal year 2026 non-GAAP adjusted free cash flow outlook to $3.0 to $3.5 billion release 2025-10-30 | |||
| Diluted EPS (company-defined) Fiscal 2026 (ended 2026-06-30) |
Given $9.30 to $9.50 release 2025-08-12
Raised $9.65 to $9.85 release 2025-10-30
Raised $10.15 to $10.35 release 2026-02-05
Raised $10.70 to $10.80 release 2026-04-30
|
– | No standard number |
The company's wordsThe company raised its fiscal year 2026 outlook for non-GAAP diluted EPS to $9.30 to $9.50 (+13% to +15% growth), a $0.20 increase from the preliminary outlook of $9.10 to $9.30 previously communicated during the company’s 2025 Investor Day. release 2025-08-12 Fiscal year 2026 outlook … Cardinal Health is raising its guidance for non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $9.65 to $9.85 (+17% to +20% growth). release 2025-10-30 Cardinal Health is raising its fiscal year 2026 guidance for non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $10.15 to $10.35 (+23% to +26% growth). release 2026-02-05 Cardinal Health is raising and narrowing its fiscal year 2026 guidance for non- GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $10.70 to $10.80 (+30% to +31% growth). release 2026-04-30 | |||
| Free cash flow (company-defined) Fiscal 2025 (ended 2025-06-30) |
Given $1.00B to $1.50B release 2024-11-01
|
– | No standard number |
The company's wordsFiscal year 2025 outlook … Additionally, the company updated expectations for its adjusted free cash flow to $1.0 billion to $1.5 billion, from approximately $1.0 billion. release 2024-11-01 | |||
| Capital expenditures Fiscal 2025 (ended 2025-06-30) |
Given $500.00M to $550.00M release 2024-08-14
|
$547.00M 10-K filed 2025-08-12 |
Within the range |
The company's wordsThe company also improved its fiscal year 2025 outlooks for Interest and other, diluted weighted average shares outstanding and share repurchases 4 . … Capital Expenditures $500M to $550M release 2024-08-14 | |||
| Diluted EPS (company-defined) Fiscal 2025 (ended 2025-06-30) |
Given at least $7.50 release 2024-05-02
Changed $7.55 to $7.70 release 2024-08-14
Raised $7.75 to $7.90 release 2024-11-01
Raised $7.85 to $8.00 release 2025-01-30
Raised $8.05 to $8.15 release 2025-05-01
|
– | No standard number |
The company's wordsCompany provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least $7.50 release 2024-05-02 Fiscal year 2025 non-GAAP EPS guidance raised to $7.55 to $7.70, from at least $7.50 release 2024-08-14 The company raised its fiscal 2025 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to $7.75 to $7.90, from $7.55 to $7.70. release 2024-11-01 The company raised its fiscal 2025 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to $7.85 to $8.00, from $7.75 to $7.90. release 2025-01-30 The company raised and narrowed its fiscal 2025 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to $8.05 to $8.15, from $7.85 to $8.00. release 2025-05-01 | |||
| Diluted EPS (company-defined) Fiscal 2024 (ended 2024-06-30) |
Given $6.75 to $7.00 release 2024-01-09
Raised $7.20 to $7.35 release 2024-02-01
Raised $7.30 to $7.40 release 2024-05-02
|
– | No standard number |
The company's wordsUpdated fiscal 2024 non-GAAP diluted EPS guidance to high end of $6.75 to $7.00 range release 2024-01-09 Fiscal 2024 non-GAAP EPS guidance raised to $7.20 to $7.35, from $6.75 to $7.00 release 2024-02-01 The company raised and narrowed its fiscal year 2024 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. to $7.30 to $7.40, from $7.20 to $7.35. release 2024-05-02 | |||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (14 releases since 2023-11-03), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.